Symbescaline

Symbescaline
Clinical data
Other namesSB; 3,5-Diethoxy-4-methoxyphenethylamine
Routes of
administration		Oral[1]
ATC code
  • None
Pharmacokinetic data
Duration of actionUnknown[1]
Identifiers
  • 2-(3,5-diethoxy-4-methoxyphenyl)ethan-1-amine
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC13H21NO3
Molar mass239.315 g·mol−1
3D model (JSmol)
  • COc1c(cc(cc1OCC)CCN)OCC
  • InChI=1S/C13H21NO3/c1-4-16-11-8-10(6-7-14)9-12(17-5-2)13(11)15-3/h8-9H,4-7,14H2,1-3H3 Y
  • Key:ROKMKYBLAPLLER-UHFFFAOYSA-N Y
 NY (what is this?)  (verify)

Symbescaline (SB), or 3,5-diethoxy-4-methoxyphenethylamine, is a drug.[1] It is an isomer of asymbescaline.[1] Symbescaline was first synthesized by Alexander Shulgin.[1] In his book PiHKAL (Phenethylamines I Have Known and Loved), the dose is listed as 240 mg, and the duration listed as unknown.[1] Symbescaline causes few effects, which include alertness and a threshold.[1] Very little data exists about the pharmacological properties, metabolism, and toxicity of symbescaline.[1]

See also

References

  1. ^ a b c d e f g h Shulgin A, Shulgin A (September 1991). PiHKAL: A Chemical Love Story. Berkeley, California: Transform Press. ISBN 0-9630096-0-5. OCLC 25627628.
This article is issued from Wikipedia. The text is available under Creative Commons Attribution-Share Alike 4.0 unless otherwise noted. Additional terms may apply for the media files.